#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    B-cell lymphoma recurrent Heavy menstrual bleeding Squamous cell carcinoma of the vulva Anaemia Leiomyosarcoma recurrent Hypomagnesaemia Adult T-cell lymphoma/leukaemia refractory PIK3CA-activated mutation Angiosarcoma Nasopharyngeal cancer Glomerulonephritis minimal lesion Factor VIII deficiency HER2 mutant non-small cell lung cancer Systemic mastocytosis Cerebral arteriovenous malformation haemorrhagic More trials…

    Learn about Rare Diseases

    Sarcoidosis Nephrotic syndrome – Trials in Disease Burkitt’s lymphoma – Life with Disease Myelodysplastic syndrome – Trials in Disease Immunodeficiency congenital – Trials in Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Pituitary-dependent Cushing’s syndrome – Treatment Brain stem glioma – Life with Disease Congenital nephrogenic diabetes insipidus – Diagnostics Gastrointestinal stromal tumour – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isotretinoin Eight Treg Rivaroxaban Gallium (68Ga) Bnt314 Maraviroc Dexibuprofen ALN-4324 Heparin Calcium Garadacimab Mavorixafor Ecoo6A Inclisiran Sodium Thymalfasin Trifluridine Sibeprenlimab LUMC-BOB1-B7-TCR.1 Ag-946 Phosphate Lapatinib Tocilizumab More therapies…

    Learn about Your Condition

    Insomnia Non-Hodgkin's lymphoma Ovarian cancer stage IV Metabolic disorder Weaning failure Anxiety Erythema migrans Nodal osteoarthritis Undifferentiated sarcoma Ischaemic stroke Prostate cancer Peritoneal cancer index Bone metabolism disorder Behcet's syndrome Thymic carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myeloid leukaemia

  • Study of Gilteritinib and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in Patients Not Eligible for Intensive Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gilteritinib
    • Azacitidine
    Belgium Germany

  • Study of Venetoclax and Low Dose Cytarabine for Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Cytarabine
    • Venetoclax
    France

  • Study of venetoclax and azacitidine treatment in adults with NPM1-mutated acute myeloid leukemia who experience molecular relapse or disease progression

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Italy

  • Study of Pivekimab Sunirine for Adults with CD123-positive Acute Myeloid Leukemia and Other CD123-positive Blood Cancers

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Pivekimab Sunirine
    France Spain

  • Study of Cusatuzumab and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cusatuzumab
    • Azacitidine
    Spain

  • Study of Venetoclax and Azacitidine for Patients with Untreated Acute Myeloid Leukemia Who Cannot Have Standard Induction Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Belgium Czechia Finland France Hungary Spain
Previous Page
1 … 16 17 18 19 20 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!